Hurdle technology using encapsulated enzymes and essential oils to fight bacterial biofilms.
Samah MechmechaniSimon KhelissaAdem GharsallaouiKhaled El OmariMonzer HamzeNour-Eddine ChihibPublished in: Applied microbiology and biotechnology (2022)
Biofilm formation on abiotic surfaces has become a major public health concern because of the serious problems they can cause in various fields. Biofilm cells are extremely resistant to stressful conditions, because of their complex structure impedes antimicrobial penetration to deep-seated cells. The increased resistance of biofilm to currently applied control strategies underscores the urgent need for new alternative and/or supplemental eradication approaches. The combination of two or more methods, known as Hurdle technology, offers an excellent option for the highly effective control of biofilms. In this perspective, the use of functional enzymes combined with biosourced antimicrobial such as essential oil (EO) is a promising alternative anti-biofilm approach. However, these natural antibiofilm agents can be damaged by severe environmental conditions and lose their activity. The microencapsulation of enzymes and EOs is a promising new technology for enhancing their stability and improving their biological activity. This review article highlights the problems related to biofilm in various fields, and the use of encapsulated enzymes with essential oils as antibiofilm agents. KEY POINTS: • Problems associated with biofilms in the food and medical sectors and their subsequent risks on health and food quality. • Hurdle technology using enzymes and essential oils is a promising strategy for an efficient biofilms control. • The microencapsulation of enzymes and essential oils ensures their stability and improves their biological activities.
Keyphrases
- candida albicans
- biofilm formation
- staphylococcus aureus
- pseudomonas aeruginosa
- public health
- mental health
- induced apoptosis
- human health
- healthcare
- cell cycle arrest
- escherichia coli
- essential oil
- cystic fibrosis
- endoplasmic reticulum stress
- risk assessment
- health information
- signaling pathway
- early onset
- transcription factor
- drug induced